Asia-pacific Biomaterials Market Forecast 2022-2030

Asia-pacific Biomaterials Market Forecast 2022-2030

KEY FINDINGS

The Asia-Pacific biomaterials market is expected to rise with a CAGR of 14.01% during the forecast period, 2022-2030. The rising urbanization, steady population growth, and the presence of multiple small and medium businesses (SMBs) are driving the market growth in the region.

MARKET INSIGHTS

The Asia-Pacific biomaterials market growth assessment includes the analysis of Vietnam, India, South Korea, Thailand, China, Japan, Indonesia, Australia & New Zealand, and Rest of Asia-Pacific. There is a large prevalence of orthopedic disorders, cardiovascular diseases, and road accidents in India due to the large population base. As a result, there is a high demand for surgical procedures involving bone graft substitutes and bone transplants. The prevalence of cardiac disorders and the increasing number of pacemaker procedures in India are expected to drive the biomaterials demand during the forecast period.

Moreover, the South Korean Ministry of Energy launched a coexistent development committee in 2019 that would be responsible for the growing activities of the Biomaterials industry of South Korea. This committee consists of 20 individuals from various industries, research firms, and academic backgrounds. The country is also focusing on improving the R&D of Biomaterials producing technologies artificial intelligence, thereby leveraging the growth opportunities of the biomaterials market.

Further, the Indonesian government has set policies and clear roadmaps to ensure medical devices’ availability and distribution. These initiatives have also increased the demand for biomaterials in Indonesia, contributing to the Indonesia biomaterial market growth.

COMPETITIVE INSIGHTS

Some of the eminent market players in the region include Collagen Solutions PLC, Mitsubishi Chemical Holdings Corporation, Covestro AG, Evonik Industries, Dentsply Sirona, etc.

Our report offerings include:
Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Usage Of Biomaterials In Bone Fixation And Plastic Surgeries
3.1.2. Prevalence Of Geriatric Population And Cardiovascular Diseases
3.1.3. Government Support For Research And Development Initiatives
3.1.4. Applications Of Biomaterials In Plastic Surgeries And Wound Healing Therapies
3.2. Key Restraints
3.2.1. Biocompatibility Issues Associated With Biomaterial
3.2.2. Stringent Regulations
3.2.3. High Price Of The Implantable Biomaterials
4. Key Analytics
4.1. Impact Of Covid-19 On Biomaterials Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
5. Market By Product
5.1. Metal-based Biomaterials
5.1.1. Stainless Steel
5.1.2. Titanium And Titanium Alloys
5.1.3. Co-cr Alloys
5.1.4. Magnesium
5.1.5. Gold
5.1.6. Silver
5.1.7. Nitinol
5.1.8. Other Metal-based Biomaterials
5.2. Polymer-based Biomaterials
5.2.1. Pmma
5.2.2. Polyethylene Terephthalate
5.2.3. Polyester
5.2.4. Polyvinylchloride
5.2.5. Silicone Rubber
5.2.6. Nylon
5.2.7. Polyetheretherketone
5.2.8. Other Polymer-based Biomaterials
5.3. Ceramic-based Biomaterials
5.3.1. Calcium Phosphate
5.3.2. Aluminum Oxide
5.3.3. Calcium Sulfate
5.3.4. Zirconia
5.3.5. Carbon
5.3.6. Glass
5.4. Natural Biomaterials
5.4.1. Hyaluronic Acid
5.4.2. Fibrin
5.4.3. Collagen & Gelatin
5.4.4. Cellulose
5.4.5. Chitin
5.4.6. Alginates
5.4.7. Silk
5.5. Inorganic Glass-based Biomaterials
5.6. Radiopaque Biomaterials
5.7. Regenerative Biomaterials
5.8. Hybrid Biomaterial Combinations
6. Market By Application
6.1. Cardiovascular
6.1.1. Catheters
6.1.2. Stents
6.1.3. Heart Valves
6.1.4. Pacemakers
6.1.5. Implantable Cardiac Defibrillators
6.1.6. Vascular Grafts
6.1.7. Guidewires
6.1.8. Sensors
6.2. Orthopedic
6.2.1. Joint Replacement
6.2.2. Fracture Fixation
6.2.3. Spine Adjustments
6.2.4. Orthobiology
6.2.5. Viscosupplementation
6.2.6. Bioresorbable Tissue Fixation
6.3. Ophthalmology
6.3.1. Contact Lenses
6.3.2. Intraocular Lenses
6.3.3. Functional Replacement Of Ocular Tissues
6.3.4. Synthetic Corneas
6.3.5. Other Ophthalmology Applications
6.4. Dental
6.4.1. Dental Bone Grafts And Substitutes
6.4.2. Dental Membranes
6.5. Wound Healing
6.5.1. Staples
6.5.2. Wound Closure Devices
6.5.3. Sutures
6.5.4. Hernia Meshes
6.5.5. Surgical Haemostats
6.5.6. Internal Tissue Sealants
6.5.7. Adhesion Barriers
6.6. Plastic Surgeries
6.6.1. Craniofacial Surgeries
6.6.2. Soft-tissue Fillers
6.7. Neurological/Central Nervous System
6.7.1. Shunting Systems
6.7.2. Neural Stem Cell Encapsulation
6.7.3. Cortical Neural Prosthetics (Cnp)
6.7.4. Hydrogel Scaffolds
6.8. Tissue Engineering
6.8.1. Tailoring Of Inorganic Nanoparticles
6.8.2. Scaffolds For Regenerative Medicines
6.8.3. Nanomaterial For Biosensing
6.9. Other Applications
6.9.1. Urinary Applications
6.9.2. Drug Delivery Systems
6.9.3. Bariatric Surgeries
6.9.4. Gastrointestinal Applications
7. Geographical Analysis
7.1. Asia-pacific
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. China
7.1.5.2. Japan
7.1.5.3. India
7.1.5.4. South Korea
7.1.5.5. Indonesia
7.1.5.6. Thailand
7.1.5.7. Vietnam
7.1.5.8. Australia & New Zealand
7.1.5.9. Rest Of Asia-pacific
8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships & Agreements
8.1.4. Business Expansions & Divestitures
8.2. Company Profiles
8.2.1. Basf
8.2.2. Bbs-bioactive Bone Substitutes
8.2.3. Bioretec Ltd
8.2.4. Carpenter Technology Corporation
8.2.5. Celanese Corporation
8.2.6. Collagen Solutions Plc
8.2.7. Corbion Nv
8.2.8. Covestro Ag
8.2.9. Dentsply Sirona
8.2.10. Evonik Industries
8.2.11. Mitsubishi Chemical Holdings Corporation
8.2.12. Noble Biomaterials Inc
8.2.13. Royal Dsm
8.2.14. Victrex Plc
8.2.15. Wright Medical Group Nv
8.2.16. Zimmer Biomet Holdings Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings